An observational study of patients with hematologic, oncologic, and other relevant conditions undergoing bone marrow imaging, with longitudinal collection of imaging, treatment, and clinical outcome data to characterize bone marrow features and changes over time
Primary Objective To establish a longitudinal cohort integrating bone marrow imaging with clinical and treatment-related data. Primary Endpoint Successful enrollment of eligible participants and collection of relevant imaging and clinical data. Secondary Objective * Characterize bone marrow imaging findings across relevant patient populations. * Evaluate relationships between imaging findings, treatment exposures, hematologic recovery, treatment-related toxicities, and clinical outcomes. * Assess longitudinal changes in bone marrow imaging findings over time and following cancer therapy. * Explore associations between imaging findings and laboratory, pathology, and research biomarker data when available.
Study Type
OBSERVATIONAL
Enrollment
1,000
Clinical, imaging, laboratory, treatment, and outcome data will be collected from institutional records and research assessments, as applicable.
UT MD Anderson Cancer Center
Houston, Texas, United States
RECRUITINGBone marrow imaging characteristics.
Evaluation of bone marrow imaging findings and longitudinal changes in patients with hematologic, oncologic, and other relevant conditions.
Time frame: Through study completion; an average of 1 year.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.